Growth Metrics

Insulet (PODD) Revenue Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 7.78%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 2.63%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 8.74%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 11.58%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 16.70%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 6.08%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 15.05%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 7.41%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 7.29%
10 Insulet 10.37 Bn 9.89 Bn 529.10 Mn 33.87%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 33.87%
Dec 31, 2025 31.18%
Sep 30, 2025 29.86%
Jun 30, 2025 32.88%
Mar 31, 2025 28.82%
Dec 31, 2024 17.20%
Sep 30, 2024 25.70%
Jun 30, 2024 23.20%
Mar 31, 2024 23.35%
Dec 31, 2023 37.90%
Sep 30, 2023 26.97%
Jun 30, 2023 32.43%
Mar 31, 2023 44.98%
Dec 31, 2022 13.06%
Sep 30, 2022 23.66%
Jun 30, 2022 15.20%
Mar 31, 2022 -1.00%
Dec 31, 2021 32.87%
Sep 30, 2021 17.78%
Jun 30, 2021 14.85%
Mar 31, 2021 26.01%
Dec 31, 2020 17.53%
Sep 30, 2020 21.81%
Jun 30, 2020 27.78%
Mar 31, 2020 24.06%
Dec 31, 2019 26.99%
Sep 30, 2019 27.13%
Jun 30, 2019 42.59%
Mar 31, 2019 29.13%
Dec 31, 2018 26.34%
Sep 30, 2018 24.08%
Jun 30, 2018 13.16%
Mar 31, 2018 21.52%
Dec 31, 2017 26.02%
Sep 30, 2017 28.36%
Jun 30, 2017 25.68%
Mar 31, 2017 25.24%
Dec 31, 2016 23.60%
Sep 30, 2016 32.89%
Jun 30, 2016 44.23%
Mar 31, 2016 68.67%
Dec 31, 2015 15.49%
Sep 30, 2015 -4.79%
Jun 30, 2015 -15.92%
Mar 31, 2015 -30.38%
Dec 31, 2014 5.88%
Sep 30, 2014 22.72%
Jun 30, 2014 19.84%
Mar 31, 2014 20.58%
Dec 31, 2013 18.51%
Sep 30, 2013 11.60%
Jun 30, 2013 17.75%
Mar 31, 2013 20.11%
Dec 31, 2012 22.54%
Sep 30, 2012 22.78%
Jun 30, 2012 58.44%
Mar 31, 2012 68.99%
Dec 31, 2011 69.96%
Sep 30, 2011 75.19%
Jun 30, 2011 40.43%